BACKGROUND: Previous research showed that the intracellular complement system, with CD46 as its central molecule, regulates the Th1 response associated with IFN-γ production and transition to a type 1 regulatory response (Tr1) characterized by IL-10 production. This transition can be influenced by a vitamin D (calcitriol), favouring a shift towards Tr1 cells and increased IL-10 production, as described in some autoimmune diseases. OBJECTIVE: It is unknown whether calcitriol modulates CD46-induced Th1 response towards regulatory type 1 T cells (Tr1) in allergic eosinophilic asthma and its value in relation to reducing inflammatory response. METHODS: CD4+ T cells from 58 patients with allergic eosinophilic asthma (AEA) and 49 healthy donors (HDs) were stimulated with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol in vitro for 60 h and analyzed by flow cytometry. IFN-γ and IL-10 levels in cell culture supernatants were measured using ELISA. RESULTS: CD4+ T cells from patients with AEA demonstrated elevated CD46 expression in both the non-activated state and under stimulation conditions with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol. Moreover, CD46 expression in AEA patients fluctuated with the pollen season, showing a significant increase during period of low pollen exposure. Calcitriol further induced CD4+Tr1 cells from in vitro generated CD4+Th1 cells in both HDs and AEA patients. However, in both cohorts were individuals (HDs: 35/49, AEA: 40/58) who responded to calcitriol with a more pronounced regulatory response. The calcitriol-induced regulatory effect manifested by a stronger surface decrease of CD46 on activated CD4+ T cells (by 40% in HDs and by 26% in AEA), accompanied by a significant inhibition of IFN-γ and increased IL-10 production (by 31% in HDs and by 85% in AEA). These individuals were termed as the CD46D group. Contrary to this, calcitriol induced an increase in CD46 expression at the CD4+ T cell surface in a minor group of HDs (14/49), and AEA patients (18/58), who were termed as the CD46I group. In CD46I group, CD4+ T cells produced less IFN-γ in comparison with CD46D group (by 33% in HDs and by 43% in AEA) and were unable to upregulate IL-10 production following stimulation with αCD3/αCD46/IL-2/Calcitriol. CONCLUSION: Our results suggest the potential existence of a key for stratifying individuals suitable for calcitriol treatment in the context of low serum vitamin D levels. After validation in clinical studies, this key could be used as an adjunctive therapy not only for patients with allergic eosinophilic asthma, but also for other diseases.

Department of Economics Faculty of Business and Economics Mendel University Brno Czechia

Faculty of Medicine Institute of Clinical Immunology and Allergology Masaryk University Brno Czechia

Institute of Clinical Immunology and Allergology St Anne's University Hospital Brno Czechia

Zobrazit více v PubMed

Erle DJ, Sheppard D. The cell biology of asthma. J Cell Biol. (2014) 205:621–31. 10.1083/jcb.201401050 PubMed DOI PMC

Geehan E, Ibrahim E, Heba E, Tamer E. Role of synergism between RV infection and atopy in the pathophysiology of intermittent asthmatic bronchitis in adolescent group in Mansoura. Egypt J Med Microbiol. (2015) 24:59–70. 10.12816/0024810 DOI

West EE, Kemper C. Complosome — the intracellular complement system. Nat Rev Nephrol. (2023) 19:426–39. 10.1038/s41581-023-00704-1 PubMed DOI PMC

Dimeloe S, Nanzer A, Ryanna K, Hawrylowicz C. Regulatory T cells, inflammation and the allergic response—the role of glucocorticoids and Vitamin D. J Steroid Biochem Mol Biol. (2010) 120:86–95. 10.1016/j.jsbmb.2010.02.029 PubMed DOI

Cardone J, Le Friec G, Vantourout P, Roberts A, Fuchs A, Jackson I, et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat Immunol. (2010) 11:862–71. 10.1038/ni.1917 PubMed DOI PMC

Choileain SN, Weyand NJ, Neumann C, Thomas J, So M, Astier AL. The dynamic processing of CD46 intracellular domains provides a molecular rheostat for T cell activation. PLoS One. (2011) 6:e16287. 10.1371/journal.pone.0016287 PubMed DOI PMC

Cope A, Le Friec G, Cardone J, Kemper C. The Th1 life cycle: molecular control of IFN-γ to IL-10 switching. Trends Immunol. (2011) 32:278–86. 10.1016/j.it.2011.03.010 PubMed DOI

Kongsbak M, von Essen MR, Boding L, Levring TB, Schjerling P, Lauritsen JPH, et al. Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells. PLoS One. (2014) 9:e96695. 10.1371/journal.pone.0096695 PubMed DOI PMC

Kongsbak M, Levring T, Geisler C, von Essen M. The vitamin D receptor and T cell function. Front Immunol. (2013) 4:148. 10.3389/fimmu.2013.00148 PubMed DOI PMC

Minton K. Vitamin D shuts down T cell-mediated inflammation. Nat Rev Immunol. (2022) 22:1. 10.1038/s41577-021-00663-3 PubMed DOI PMC

Astier A, Kickler K, Ni Choileain S. Vitamin D promotes Tr1 differentiation through the CD46 pathway (178.18). J Immunol. (2012) 188:178.18. 10.4049/jimmunol.188.Supp.178.18 DOI

Lim S, Crawley E, Woo P, Barnes PJ. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet. (1998) 352:113. 10.1016/S0140-6736(98)85018-6 PubMed DOI

Raeiszadeh Jahromi S, Mahesh PA, Jayaraj BS, Madhunapantula SRV, Holla AD, Vishweswaraiah S, et al. Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case–control study. J Asthma. (2014) 51:1004–13. 10.3109/02770903.2014.938353 PubMed DOI

Xu Y-Q, Gao Y-D, Yang J, Guo W. A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients. J Asthma. (2010) 47:367–73. 10.3109/02770903.2010.481340 PubMed DOI

Green J W, Vasanthakumar D. Does vitamin D supplementation reduce risk of asthma exacerbation and improve asthma control? Clin Exp Allergy J Br Soc Allergy Clin Immunol. (2023) 53:1239–42. 10.1111/cea.14410 PubMed DOI

Liu M, Wang J, Sun X. A meta-analysis on vitamin D supplementation and asthma treatment. Front Nutr. (2022) 9:860628. 10.3389/fnut.2022.860628 PubMed DOI PMC

Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al. Global initiative for asthma strategy 2021: executive summary and rationale for key changes. Am J Respir Crit Care Med. (2022) 205:17–35. 10.1164/rccm.202109-2205PP PubMed DOI PMC

Kreher CR, Dittrich MT, Guerkov R, Boehm BO, Tary-Lehmann M. CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J Immunol Methods. (2003) 278:79–93. 10.1016/S0022-1759(03)00226-6 PubMed DOI

Kickler K, Choileain SN, Williams A, Richards A, Astier AL. Calcitriol modulates the CD46 pathway in T cells. PLoS One. (2012) 7:e48486. 10.1371/journal.pone.0048486 PubMed DOI PMC

Rasquinha MT, Sur M, Lasrado N, Reddy J. IL-10 as a Th2 cytokine: differences between mice and humans. J Immunol Baltim Md 1950. (2021) 207:2205–15. 10.4049/jimmunol.2100565 PubMed DOI PMC

Gray D, Gray M. What are regulatory B cells? Eur J Immunol. (2010) 40:2677–9. 10.1002/eji.201040961 PubMed DOI

Ni Choileain S, Astier AL. CD46 plasticity and its inflammatory bias in multiple sclerosis. Arch Immunol Ther Exp. (2011) 59:49–59. 10.1007/s00005-010-0109-7 PubMed DOI PMC

Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as Pathogens’ magnet. J Virol. (2004) 78:4385–8. 10.1128/JVI.78.9.4385-4388.2004 PubMed DOI PMC

Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature. (2003) 421:388–92. 10.1038/nature01315 PubMed DOI

Le Friec G, Sheppard D, Whiteman P, Karsten CM, Shamoun SA-T, Laing A, et al. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat Immunol. (2012) 13:1213–21. 10.1038/ni.2454 PubMed DOI PMC

van den Berg CW, de Andrade RMG, Magnoli FC, Marchbank KJ, Tambourgi DV. Loxosceles spider venom induces metalloproteinase mediated cleavage of MCP/CD46 and MHCI and induces protection against C-mediated lysis. Immunology. (2002) 107:102–10. 10.1046/j.1365-2567.2002.01468.x PubMed DOI PMC

Hansen AS, Slater J, Biltoft M, Bundgaard BB, Møller BK, Höllsberg P. CD46 Is a potent co-stimulatory receptor for expansion of human IFN-γ-producing CD8+ T cells. Immunol Lett. (2018) 200:26–32. 10.1016/j.imlet.2018.06.003 PubMed DOI PMC

Travers J, Rothenberg ME. Eosinophils in mucosal immune responses. Mucosal Immunol. (2015) 8:464–75. 10.1038/mi.2015.2 PubMed DOI PMC

Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. In: Dixon FJ, Austen KF, Hood LE, Uhr JW, editors. Advances in Immunology. United States: Academic Press; (1986). p. 177–253. 10.1016/S0065-2776(08)60351-X PubMed DOI

Motojima S, Tateishi K, Koseki T, Makino S, Fukuda T. Serum levels of eosinophil cationic protein and IL-5 in patients with asthma without systemic corticosteroids. Int Arch Allergy Immunol. (1997) 114(1):55–9. 10.1159/000237719 PubMed DOI

Kocak AK, Bor O, Yildiz B, Erdogan L, Us T. T-lymphocyte activation and the levels of eosinophilic cationic protein and interleukin-5 in asthmatic children with acute exacerbation and effect of glucocorticoid treatment. Allergy Asthma Proc. (2006) 27:371–7. 10.2500/aap.2006.27.2885 PubMed DOI

Kolev M, Dimeloe S, Le Friec G, Navarini A, Arbore G, Povoleri GA, et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity. (2015) 42:1033–47. 10.1016/j.immuni.2015.05.024 PubMed DOI PMC

Kunz N, Kemper C. Complement has brains—do intracellular complement and immunometabolism cooperate in tissue homeostasis and behavior? Front Immunol. (2021) 12:629986. 10.3389/fimmu.2021.629986 PubMed DOI PMC

Kabat AM, Pearce EL, Pearce EJ. Metabolism in type 2 immune responses. Immunity. (2023) 56:723–41. 10.1016/j.immuni.2023.03.007 PubMed DOI PMC

Aranow C. Vitamin D and the immune system. J Investig Med Off Publ Am Fed Clin Res. (2011) 59:881–6. 10.231/JIM.0b013e31821b8755 PubMed DOI PMC

Hall SC, Agrawal DK. Vitamin D and bronchial asthma: an overview of data from the past 5 years. Clin Ther. (2017) 39:917–29. 10.1016/j.clinthera.2017.04.002 PubMed DOI PMC

Killick J, Hay J, Morandi E, Vermeren S, Kari S, Angles T, et al. Vitamin D/CD46 crosstalk in human T cells in multiple sclerosis. Front Immunol. (2020) 11:598727. 10.3389/fimmu.2020.598727 PubMed DOI PMC

Zhu Y, Jing D, Liang H, Li D, Chang Q, Shen M, et al. Vitamin D status and asthma, lung function, and hospitalization among British adults. Front Nutr. (2022) 9:954768. 10.3389/fnut.2022.954768 PubMed DOI PMC

Bener A, Ehlayel MS, Tulic MK, Hamid Q. Vitamin D deficiency as a strong predictor of asthma in children. Int Arch Allergy Immunol. (2012) 157:168–75. 10.1159/000323941 PubMed DOI

Park CS, Lee SM, Chung SW, Uh S, Kim HT, Kim YH. Interleukin-2 and soluble lnterleukin-2 receptor in bronchoalveolar lavage fluid from patients with bronchial asthma. Chest. (1994) 106:400–6. 10.1378/chest.106.2.400 PubMed DOI

Levings MK, Sangregorio R, Roncarolo M-G. Human Cd25+Cd4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. (2001) 193:1295–302. 10.1084/jem.193.11.1295 PubMed DOI PMC

Earle KE, Tang Q, Zhou X, Liu W, Zhu S, Bonyhadi ML, et al. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol. (2005) 115:3–9. 10.1016/j.clim.2005.02.017 PubMed DOI PMC

Tsai Y-G, Niu D-M, Yang KD, Hung C-H, Yeh Y-J, Lee C-Y, et al. Functional defects of CD46-induced regulatory T cells to suppress airway inflammation in mite allergic asthma. Lab Invest. (2012) 92:1260–9. 10.1038/labinvest.2012.86 PubMed DOI

Tosato F, Bucciol G, Pantano G, Putti MC, Sanzari MC, Basso G, et al. Lymphocytes subsets reference values in childhood. Cytometry A. (2015) 87:81–5. 10.1002/cyto.a.22520 PubMed DOI

ten Hacken N, Oosterhoff Y, Kauffman HF, Guevarra L, Satoh T, Tollerud DJ, et al. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur Respir J. (1998) 11:312–6. 10.1183/09031936.98.11020312 PubMed DOI

Wisniewski JA, Muehling LM, Eccles JD, Capaldo BJ, Agrawal R, Shirley D-A, et al. TH1 Signatures are present in the lower airways of children with severe asthma, regardless of allergic status. J Allergy Clin Immunol. (2018) 141:2048–2060.e13. 10.1016/j.jaci.2017.08.020 PubMed DOI PMC

Steinke JW, Lawrence MG, Teague WG, Braciale TJ, Patrie JT, Borish L. Bronchoalveolar lavage cytokine patterns in children with severe neutrophilic and paucigranulocytic asthma. J Allergy Clin Immunol. (2021) 147:686–693.e3. 10.1016/j.jaci.2020.05.039 PubMed DOI PMC

Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. (2002) 51:1367–74. 10.2337/diabetes.51.5.1367 PubMed DOI

Andjelkovic Z, Vojinovic J, Pejnovic N, Popovic M, Dujic A, Mitrovic D, et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol. (1999) 17:453–6. PubMed

Vaisberg MW, Kaneno R, Franco MF, Mendes NF. Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice. J Clin Lab Anal. (2000) 14:91–6. 10.1002/(sici)1098-2825(2000)14:3<91::aid-jcla2>3.0.co;2-o PubMed DOI PMC

Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis. (2010) 69:1155–7. 10.1136/ard.2009.120329 PubMed DOI

Ardizzone S, Cassinotti A, Trabattoni D, Manzionna G, Rainone V, Bevilacqua M, et al. Immunomodulatory effects of 1,25-ihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol. (2009) 22:63–71. 10.1177/039463200902200108 PubMed DOI

Afsal K, Selvaraj P, Harishankar M. 1, 25-dihydroxyvitamin D3 downregulates cytotoxic effector response in pulmonary tuberculosis. Int Immunopharmacol. (2018) 62:251–60. 10.1016/j.intimp.2018.07.018 PubMed DOI

Yeh C-L, Wu J-M, Yang P-J, Lee P-C, Chen K-Y, Yeh S-L, et al. Intravenous calcitriol treatment benefits the homeostasis of CD4+ T cells and attenuates kidney injury in obese mice complicated with polymicrobial sepsis. Nutrition. (2022) 103–104:111741. 10.1016/j.nut.2022.111741 PubMed DOI

Usategui-Martín R, De Luis-Román D-A, Fernández-Gómez JM, Ruiz-Mambrilla M, Pérez-Castrillón J-L. Vitamin D receptor (VDR) gene polymorphisms modify the response to vitamin D supplementation: a systematic review and meta-analysis. Nutrients. (2022) 14:360. 10.3390/nu14020360 PubMed DOI PMC

Saccone D, Asani F, Bornman L. Regulation of the vitamin D receptor gene by environment, genetics and epigenetics. Gene. (2015) 561:171–80. 10.1016/j.gene.2015.02.024 PubMed DOI